Sakariassen K S, Nievelstein P F, Coller B S, Sixma J J
Br J Haematol. 1986 Aug;63(4):681-91. doi: 10.1111/j.1365-2141.1986.tb07552.x.
Platelet adherence to human artery subendothelium in blood from eight normal subjects, four patients with Glanzmann's thrombasthenia (deficiency of platelet membrane glycoproteins IIb and IIIa: GPIIb-IIIa), two patients with Bernard-Soulier syndrome (deficiency of platelet membrane glycoprotein Ib: GPIb) and one patient with von Willebrand's disease (VWD subtype III. deficient in factor VIII-von Willebrand factor: FVIII-VWF) was compared at various wall shear rates (300, 500, 1000, 1800 and 2500 s-1). Platelet adherence in blood from the patients with Glanzmann's thrombasthenia was within the normal range at shear rates below 1000 s-1. There was some decrease in adhesion at higher shear rates and platelets were less spread out on the subendothelium than normally at all shear rates. Platelet aggregate formation was almost totally absent. Platelet adherence in blood from patients with the Bernard-Soulier syndrome was strongly impaired at all shear rates. Platelet adherence in blood from the patient with VWD subtype III was normal at shear rates of 300 and 500 s-1, but impaired at shear rates above 1000 s-1. Aggregate formation was also decreased at these shear rates. Platelet adhesion was strongly inhibited by a monoclonal antibody against glycoprotein Ib, which had previously been shown to inhibit ristocetin-induced aggregation, at shear rates of 500 and 1800 s-1 but not at 300 s-1. Platelet adhesion at 1800 s-1 was also inhibited, though to a lesser extent, by two antibodies against GPIIb-IIIa. These antibodies also inhibited platelet aggregate formation. The data indicates that GPIb is involved in adhesion at the same shear rates as von Willebrand factor. Absence or inhibition of GPIIb-IIIa primarily causes a defect of aggregate formation but GPIIb-IIIa may also play a role in adhesion, particularly at high shear rates. The defect of adhesion in the Bernard-Soulier syndrome may be dependent on factors other than a deficiency of GPIb alone.
比较了8名正常受试者、4名患有Glanzmann血小板无力症(血小板膜糖蛋白IIb和IIIa缺乏:GPIIb-IIIa)的患者、2名患有Bernard-Soulier综合征(血小板膜糖蛋白Ib缺乏:GPIb)的患者以及1名患有血管性血友病(VWD III型,缺乏因子VIII-血管性血友病因子:FVIII-VWF)的患者血液中血小板在不同壁面剪切速率(300、500、1000、1800和2500 s-1)下对人动脉内皮下层的黏附情况。在剪切速率低于1000 s-1时,Glanzmann血小板无力症患者血液中的血小板黏附在正常范围内。在较高剪切速率下黏附有所下降,并且在所有剪切速率下,血小板在血管内皮下层的铺展均不如正常情况。几乎完全没有血小板聚集体形成。Bernard-Soulier综合征患者血液中的血小板黏附在所有剪切速率下均受到严重损害。VWD III型患者血液中的血小板在300和500 s-1的剪切速率下黏附正常,但在高于1000 s-1的剪切速率下受到损害。在这些剪切速率下聚集体形成也减少。在500和1800 s-1的剪切速率下,一种先前已证明能抑制瑞斯托霉素诱导的聚集的抗糖蛋白Ib单克隆抗体强烈抑制血小板黏附,但在300 s-1时则无此作用。在1800 s-1时,两种抗GPIIb-IIIa抗体也抑制血小板黏附,尽管程度较轻。这些抗体也抑制血小板聚集体形成。数据表明,GPIb在与血管性血友病因子相同的剪切速率下参与黏附。GPIIb-IIIa的缺失或抑制主要导致聚集体形成缺陷,但GPIIb-IIIa也可能在黏附中起作用,尤其是在高剪切速率下。Bernard-Soulier综合征中的黏附缺陷可能取决于除GPIb缺乏之外的其他因素。